How COVID-19 Impacting Dry Eye Syndrome Market ? Top Key Players : ALLERGAN , Alcon , Novartis AG, Santen Pharmaceutical Co., Ltd. , OASIS Medical , Sun Pharmaceutical Industries Ltd , Otsuka Pharmaceutical Co., Ltd. , SentissPharma Pvt. Ltd. , Johnson &

The global dry eye syndrome market size is projected to reach USD 7.73 billion by the end of 2026. The high prevalence of dry eye syndrome has created several opportunities for the companies operating in the market. According to a published report, titled "Dry Eye Syndrome Market Size, Share and Global Trend By Product (Anti-inflammatory and, Artificial Tears and Lubricants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Geography Forecast till 2026," the market was worth USD 4.22 billion and will exhibit a CAGR of 6.9% during the forecast period, 2019-2026.

Dry eye syndrome is a critical disorder that possesses severe symptoms. The emphasis on the treatment of the disease, mainly due to its severity and potential to affect vision has created several growth opportunities for the companies operating in the market. The increasing investment in the R&D of treatment options associated with this disease will have a positive impact on the growth of the market in the coming years. Recent advancements in clinical trials associated with the disease, coupled with the increasing number of research and development activities will bode well for the market in the coming years. The presence of several reimbursement policies will emerge in favour of market growth.

The report covers :
o Global dry eye syndrome market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast time frame.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dry-eye-syndrome-market-102413

An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this [Market].

Please visit : https://www.fortunebusinessinsights.com/dry-eye-syndrome-market-102413

Leading Players operating in the Dry Eye Syndrome Market are :

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o ALLERGAN
o Alcon
o Novartis AG
o Santen Pharmaceutical Co., Ltd.
o OASIS Medical
o Sun Pharmaceutical Industries Ltd
o Otsuka Pharmaceutical Co., Ltd.
o SentissPharma Pvt. Ltd.
o Johnson & Johnson Vision Care, Inc.
o VISUfarma
o Others

Advancements in Clinical Trials Will Aid Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the advancements in clinical trial for the rugs associated with dry eye syndrome will bode well for the companies operating in the market. Several large scale companies have made progress in ongoing clinical trials. In April 2019, a clinical trial for 'A Study to Assess the Safety and Effectiveness of SJP-0035 for treatment of patients with dry eye syndrome has made progress and sponsored by the Senju Pharmaceutical Co., Ltd. is currently in phase-3 of clinical trials. Such advancements in drug trials will have a direct impact on the growth of the market in the coming years.

North America to Emerge Leading; Presence of Several Large Scale Companies Will Aid Growth
The report analyzes the ongoing diabetic dry eye treatment market trends across fiver major regions, including North America, Asia Pacific, Europe, Latin America, and the Middle East &Africa. Among all regions, the market in North America currently holds the largest market share. As of 2018, the market in North America was worth USD 2.42 billion and this value is likely to increase further in the coming years. The presence of several large scale companies in this region has contributed to the growth of the market in recent years.

Have Any Query? Ask Our Experts :
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dry-eye-syndrome-market-102413

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.